Clinical Trial Update: A Study Of Ursolic Acid For Primary Sclerosing Cholangitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ursolic acid for primary sclerosing cholangitis has been withdrawn (NCT03216876).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Ursolic acid (ursolic acid)

Snippet

Sponsor: University of California, Davis | Conditions: Primary Sclerosing Cholangitis | Phase 1 | Status: WITHDRAWN